BAYER HAS YOUR PATIENTS COVERED

For your INSURED patientsBayer products are covered by more than 89% of Managed Care Plans1

Test More - Save More:

Using the CONTOUR® Choice card - your patients can save up to $105† every month on their test strip copay*

For your CASH patientsYour patients can save up to 48% on CONTOUR®NEXT test strips, which are available at the lowest shelf price of all leading brands††

Cash patients can save up to an additional $25 every month on CONTOUR®NEXT test strips with the use of the CONTOUR® Choice card*

Patients can enroll and download a card today at www.ContourChoice.com

For your MEDICARE patientsBayer products are always covered by Medicare Part B‡. Your patients can fill their prescriptions at any retail pharmacy.

Write a branded prescription (Dispense as Written or DAW) for CONTOUR®NEXT test strips to prevent meter switching and substitution.

Ease, Accuracy, AND Savings… Now that’s a powerful combination!

1. Data on file. Bayer HealthCare, Diabetes Care.

†Patient pays first $15 of copay on prescription of 300 test strips or less and Bayer pays up to $35. For quantities over 300 test strips, patient contributions and card benefits increase accordingly – up to $45 and $105, respectively.

*Limitations and Restrictions apply. Eligible privately insured patients pay first $15 of co-payment on prescription of 300 test strips or less, and this CONTOUR® Choice co-pay card (“card”) will cover up to $35 of remaining copay, when card is presented at participating retail pharmacies with a valid prescription for Bayer test strips. For quantities over 300 test strips, patient contributions and card benefits increase accordingly – up to $45 and $105 ,respectively. Card cannot be redeemed for cash or combined with other programs, coupons, or discounts. Valid for up to 12 uses through 12/31/2016. Cash patients can visit ContourChoice.com for separate card and program details. Limit one (1) card per patient. Card cannot be redeemed for cash or combined with other programs, coupons or discounts. Not eligible for government insurance programs (e.g. Medicare/Medicaid). Void where prohibited. Bayer reserves the right to cancel this program without notice. Offer expires 12/31/2016.

††Average Retail Price, 50 ct., 52-week IRI data, 12/28/2014.

‡For diabetes monitors, test strips, lancets, and lancing devices, Medicare requires you to pay 20% of the Medicare-approved amount after your yearly Part B deductible.

Baye

r log

o pr

inte

d on

test

stri

p

Contour

®N

ext E

Z

met

er

Contour

®N

ext LIN

K

met

er

Contour

®N

ext U

SB

m

eter

Contour

®N

ext

met

er

Contour

®N

ext t

est

stri

ps

ME

TE

RS

TE

ST

ST

RIP

*10%

app

lies

to g

luco

se le

vels

≥ 10

0 m

g/dL

. In

a cli

nica

l tria

l con

duct

ed b

y Ber

nste

in e

t al.,

the

CONT

OUR®

NEXT

met

er p

ortfo

lio d

elive

red

at le

ast 9

5% o

f res

ults

with

in 1

0% o

f the

labo

rato

ry re

fere

nce

valu

e fo

r blo

od g

luco

se c

once

ntra

tions

≥10

0 m

g/dL

and

with

in ±

10 m

g/dL

of t

he la

bora

tory

refe

renc

e va

lue

for b

lood

glu

cose

con

cent

ratio

ns <

100

mg/

dL.2

**Av

erag

e Re

tail P

rice,

50

ct.,

52 w

eek

IRI d

ata,

12/

28/1

4.† T

he IS

O 15

197:

2013

sta

ndar

d re

quire

s 95

% o

f res

ults

to fa

ll with

in ±

15 m

g/dL

of l

abor

ator

y ref

eren

ce va

lue

for b

lood

glu

cose

con

cent

ratio

ns <

100

mg/

dL a

nd w

ithin

±15

% o

f lab

orat

ory r

efer

ence

valu

e fo

r blo

od g

luco

se c

once

ntra

tions

≥ 1

00 m

g/dL

, and

99%

of i

ndivi

dual

gluc

ose

mea

sure

d va

lues

sha

ll fal

l with

in zo

nes

A an

d B

of th

e Co

nsen

sus

Erro

r Grid

.3

Refe

renc

es: 2

. Ber

nste

in R

, et a

l. A

New

Test

Stri

p Te

chno

logy

Pla

tform

for S

elf-M

onito

ring

of B

lood

Glu

cose

. J D

iabe

tes

Sci T

echn

ol, 2

013,

7 (5

): 13

86-1

399.

3. I

nter

natio

nal O

rgan

izatio

n fo

r Sta

ndar

diza

tion.

In v

itro

diag

nost

ic te

st s

yste

ms—

requ

irem

ents

for b

lood

-glu

cose

mon

itorin

g sy

stem

s fo

r sel

ftest

ing

in m

anag

ing

diab

etes

mel

litus

. Gen

eva,

Switz

erla

nd:

Inte

rnat

iona

l Org

aniza

tion

for S

tand

ardi

zatio

n; 2

013.

© 2

015

Baye

r. Al

l rig

hts

rese

rved

. Bay

er (r

eg’d

), th

e Ba

yer c

ross

(reg

’d),

CONT

OUR®

, No

Codi

ng, t

he N

o Co

ding

logo

(reg

’d),

Seco

nd-C

hanc

e an

d th

e Se

cond

-Cha

nce

logo

are

trad

emar

ks o

f Bay

er.

Pat

ien

ts U

sin

g

Insu

lin W

ho

A

re A

lrea

dy

Test

ing

Pat

ien

ts

Usi

ng

Insu

lin

Wh

o W

ant

Bet

ter

Insi

gh

ts

New

ly

Dia

gn

ose

d

Pat

ien

ts

Cont

our®

Next

eZ

Cont

our®

Next

Co

ntou

r®Ne

xt U

SB

ACCURACY FEATURES

Dem

onst

rate

d hi

ghly

acc

urat

e re

sults

with

in 1

0% o

f la

b re

fere

nce

valu

es*

√√

√

Prov

en h

ighl

y acc

urat

e: m

eets

ISO† 1

5197

:201

3 ac

cura

cy cr

iteria

2

√√

√

No C

odin

g™ te

chno

logy

√√

√

Seco

nd-C

hanc

e™

sam

plin

g√

√√

BASIC FEATURES

Mem

ory

480

even

ts80

0 ev

ents

2000

eve

nts

Batte

ry li

fe10

00 te

sts

1000

test

s5

year

s (re

char

geab

le b

atte

ry)

Lang

uage

sNu

mer

ical

dis

play

Engl

ish,

Spa

nish

, and

12

oth

er la

ngua

ges

Engl

ish,

Spa

nish

, and

12

oth

er la

ngua

ges

Brig

ht b

ackl

it sc

reen

√√

5-se

cond

cou

ntdo

wn

√√

√

Smal

l blo

od

sam

ple:

0.6

μL

√√

√

ADVANCED FEATURES

Audi

ble

rem

inde

rs√

√√

Fast

ing,

Bef

ore-

Mea

l, and

Af

ter-M

eal M

arke

rsBe

fore

-Mea

l and

Af

ter-

Mea

l onl

y √

√

7-, 1

4-, 3

0-, a

nd

90-d

ay a

vera

ges

7-, 1

4-, a

nd 3

0-da

y on

ly√

√

Insu

lin a

nd c

arb

logg

ing

√

Th

e ri

ght

cho

ice

for:

The

CO

NTO

UR

®N

EX

T p

ort

folio

: H

ighl

y ac

cura

te. E

asy

to u

se w

ith

Sec

ond

-Cha

nce™

sam

plin

g.